INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE SALAMANCA
Instituto
Institut d'Investigació Biomèdica Girona
Girona, EspañaPublicaciones en colaboración con investigadores/as de Institut d'Investigació Biomèdica Girona (33)
2023
-
A multiple health behaviour change intervention to prevent depression: A randomized controlled trial
General Hospital Psychiatry, Vol. 82, pp. 86-94
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Associations of hypomagnesemia in patients seeking a first treatment of alcohol use disorder
Drug and Alcohol Dependence, Vol. 245
-
Role of personal aptitudes as determinants of incident morbidity, lifestyles, quality of life, use of health services, and mortality (DESVELA cohort): quantitative study protocol for a prospective cohort study in a hybrid analysis
Frontiers in Public Health, Vol. 11
-
Role of personal aptitudes as determinants of incident morbidity, lifestyles, quality of life, use of the health services and mortality (DESVELA cohort): qualitative study protocol for a prospective cohort study in a hybrid analysis
Frontiers in Public Health, Vol. 11
-
TTCC-2019-02: real-world evidence of first-line cetuximab plus paclitaxel in recurrent or metastatic squamous cell carcinoma of the head and neck
Frontiers in Oncology, Vol. 13
-
The Research Network on Preventive Activities and Health Promotion (redIAPP): a reference network and promoter of primary care research
Atencion Primaria, Vol. 55, Núm. 11
2022
-
Effectiveness of a multiple health-behaviour-change intervention in increasing adherence to the Mediterranean Diet in adults (EIRA study): a randomized controlled hybrid trial
BMC Public Health, Vol. 22, Núm. 1
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
2021
-
Cost-effectiveness analysis of a multiple health behaviour change intervention in people aged between 45 and 75 years: a cluster randomized controlled trial in primary care (EIRA study)
International Journal of Behavioral Nutrition and Physical Activity, Vol. 18, Núm. 1
-
Multiple health behaviour change primary care intervention for smoking cessation, physical activity and healthy diet in adults 45 to 75 years old (EIRA study): a hybrid effectiveness-implementation cluster randomised trial
BMC Public Health, Vol. 21, Núm. 1
2019
-
Capacity adiposity indices to identify metabolic syndrome in subjects with intermediate cardiovascular risk (MARK study)
PLoS ONE, Vol. 14, Núm. 1
-
Hypertension and high ankle brachial index: The overlooked combination
Journal of Hypertension, Vol. 37, Núm. 1, pp. 92-98
-
Metformin induces a fasting- and antifolate-mimicking modification of systemic host metabolism in breast cancer patients
Aging, Vol. 11, Núm. 9, pp. 2874-2888
-
Neoadjuvant metformin added to systemic therapy decreases the proliferative capacity of residual breast cancer
Journal of Clinical Medicine, Vol. 8, Núm. 12
-
Reclassification by applying the Framingham equation 30 years to subjects with intermediate cardiovascular risk. MARK study
Medicina Clinica, Vol. 153, Núm. 9, pp. 351-356
-
The C allele of ATM rs11212617 associates with higher pathological complete remission rate in breast cancer patients treated with neoadjuvant metformin
Frontiers in Oncology, Vol. 9, Núm. MAR
2018
-
A body shape index and vascular structure and function in Spanish adults (MARK study) A cross-sectional study
Medicine (United States), Vol. 97, Núm. 47
-
A phase 2 trial of neoadjuvant metformin in combination with trastuzumab and chemotherapy in women with early HER2-positive breast cancer: The METTEN study
Oncotarget, Vol. 9, Núm. 86, pp. 35687-35704
-
Effects of metabolic syndrome on arterial function in different age groups: The Advanced Approach to Arterial Stiffness study
Journal of Hypertension, Vol. 36, Núm. 4, pp. 824-833